vendredi 27 septembre 2019

Onco Actu du 27 septembre 2019


1.3 PRIX NOBEL



‘Jim Allison: Breakthrough’ Review: Taking On Cancer [NY Times]











1.4 BIOLOGIE - TECHNOS, MODÈLES



Ultrasound can ‘see’ when tumor cells turn genes on and off [Science]











2. ETIOLOGIE



Familial risk of colorectal cancer: the genes only tell part of the story [DKFZ]










Heartburn Drugs and Cancer: What Are the Risks? [WebMD]











3.1.1 PRÉVENTION - TABAC - E-CIGS



CDC reports another surge in number of cases of vaping-related illness [STAT]











Vaping-Related Illnesses Climb to 805, C.D.C. Says [NY Times]











U.S. vaping-related deaths rise to 12, illnesses climb to 805 [Reuters]











4. DÉPISTAGE, DIAGNOSTIC ET PRONOSTIC



Body-on-a-Chip Device Predicts Cancer Drug Responses [NUH Director's Blog]











4.15 DÉP., DIAG. & PRONO. - IMAGERIE



New Imaging Method Could Guide Prostate Cancer Treatment [Memorial Sloan Kettering Cancer Center]











5.10 TRAITEMENTS - ESSAIS



Adaptive Trials [In The Pipeline]











23andMe, moving beyond consumer DNA tests, is building a clinical trial recruitment business [STAT]











5.12 IMMUNOTHÉRAPIES



Oncologists listen when the FDA speaks, even after a drug hits the market [EndPoints]











Study: Cancer drug may cause metabolic imbalance, shorter survival [UPI]











5.12.11 IMMUNOTHÉRAPIES - PRÉ-CLINIQUE



What can tumours in Tasmanian devils teach us about immunotherapy resistance? [Cancer Research UK]










5.3 TRAITEMENTS - FDA, EMA, NICE...



Change of name of liposomal medicines at high risk of medication errors [EMA]











EMA advises companies on steps to take to avoid nitrosamines in human medicines [EMA]











5.3.4 TRAITEMENTS - AMM (FDA, EMA,...)



J&J’s Darzalex makes FDA history with another myeloma nod in new patients [Fierce Pharma]











Janssen Announces U.S. FDA Approval of DARZALEX® (daratumumab) Combination Regimen for Newly Diagnosed, Transplant-Eligible Patients with Multiple Myeloma [Janssen]











FDA approves daratumumab for transplant-eligible multiple myeloma [FDA]










5.6 ESMO



New Studies Question Whether Novel Anti-Cancer Drugs Are Worth Their Extra Cost [ESMO]










5.6.14 ESMO - OVAIRE



GSK, AstraZeneca rivalry takes center stage at cancer conference [Reuters]











6.1 OBSERVATION



Male infertility linked to increased prostate cancer risk [NHS Choices]










6.10 POLITIQUES



Brexit may have 'gravest of consequences' for health: UK lawmaker [Reuters]











6.11 PATIENTS



‘My body feels like it is dying from the drugs that are meant to save me’: life as a cancer patient [The Guardian]










What Do You Do When Your Patient Starts to Cry? [Medscape]










6.6 PUBLICATIONS



How researchers can improve the quality of systematic reviews [Nature]











6.7 DMP, BIG DATA & APPLIS



Statement on new steps to advance digital health policies that encourage innovation and enable efficient and modern regulatory oversight [FDA]











FDA clarifies how it will regulate digital health and artificial intelligence [STAT]










6.9 CONTROVERSES



Seven years later, NIH center that aims to speed drugs to market faces challenges [Science]